Middle molecule and small protein removal in children on peritoneal dialysis

Size: px
Start display at page:

Download "Middle molecule and small protein removal in children on peritoneal dialysis"

Transcription

1 Kidney International, Vol. 61 (2002), pp Middle molecule and small protein removal in children on peritoneal dialysis GIOVANNI MONTINI, GIANPAOLO AMICI, SABRINA MILAN, 1 MICHELE MUSSAP, MAURO NATURALE, ILSE-MARIA RÄTSCH, ANITA AMMENTI, PALMA SORINO, ENRICO VERRINA, BARBARA ANDREETTA, and GRAZIELLA ZACCHELLO, on behalf of the ITALIAN REGISTRY OF PEDIATRIC PERITONEAL DIALYSIS 2 Nephrology, Dialysis and Transplant Unit, Pediatric Department, Padova; Nephrology, Dialysis and Transplant Unit, Treviso; Department of Laboratory Medicine, Padova; Nephrology and Dialysis Unit, Pediatric Department, Parma; Nephrology and Dialysis Unit, Pediatric Department, Ancona; Nephrology and Dialysis Unit, Bari; and Nephrology, Dialysis and Transplant Unit, Genova, Italy Middle molecule and small protein removal in children on perifor 1.73 m 2 ) and weekly solute removal index (SRI) were calculated toneal dialysis. all the solutes; weekly Kt/V was calculated for urea. Background. Dialysis efficiency has a great influence on the Results. In non-anuric versus anuric patients the total clearoutcome of patients. Few data are available on the removal of ances were: urea versus ; creatinine 82.7 solutes with molecular weights higher than urea and creatinine versus ; inulin versus ; The aim of our study was to assess the transport and the re- 2 m versus ; cystatin C versus moval of substances with molecular weights up to 15 kd and In the patients with residual diuresis, the urea was to evaluate the contribution of residual renal function in perito- removed mainly by PD (69.2%), while inulin, 2 m and cystatin neal dialysis (PD) children. C were removed by renal clearance (64.0%, 79.5% and 62.8%, Methods. Seventeen patients of 12 4 years undergoing autoin respectively). Total, peritoneal and renal weekly Kt/V values mated PD were studied. Ten patients had ml/ the subjects with residual renal function, were , day of urine output, and 7 were anuric. During a standardized and , respectively. Peritoneal weekly nightly intermittent PD (NIPD) session, a single-injection inuin Kt/V in the anuric patients was ; total weekly Kt/V lin clearance was performed. Urea, creatinine, inulin (meaversus the total group was Weekly SRIs in non-anuric sured by HPLC), cystatin C and 2 -microglobulin ( 2 m) were anuric patients were: urea versus 2.09 measured in blood, urine and dialysate. Clearances (L/week/ 0.74; creatinine versus ; inulin versus ; 2 m versus ; cystatin C versus S.M. is presently at the Nephrology Unit of Castelfranco. Conclusions. Solutes removed during PD tend to decrease fol- 2 Investigators and their affiliated institutions participating in the Italian lowing an increase in molecular weight of the substance. Since Registry of Pediatric Peritoneal Dialysis include: I. Rätsch (Nephrology anuric patients are at higher risk of middle molecule and small and dialysis unit, Ancona); D.A. Caringella, P. Sorino (Nephrology and protein accumulation, more attention should be paid to the dialysis unit, Giovanni XXIII Hospital, Bari); L. Catizone, (Nephrology removal of middle molecules. Further studies should be underand dialysis unit, Malpighi Hospital, Bologna); G. Cancarini (Nephrol- taken to evaluate whether removing them has a clinical impact ogy and dialysis unit, Brescia); G. Lavoratti (Pediatric department, Meyer and to determine their threshold levels. Hospital, Firenze); F. Perfumo, E. Verrina (Nephrology, dialysis and transplant unit, Istituto G. Gaslini, Genova); A. Edefonti (Nephrology, dialysis and transplant unit, Department of pediatrics, De Marchi, Milano); C. Pecoraro (Nephrology and dialysis unit, Santobono Hospital, Napoli); G. Zacchello, B. Andreetta (Nephrology dialysis and transplant Uremic toxicity closely depends on the accumulation unit, Università, Padova); S. Maringhini 3 (Nephrology and dialysis unit, of many substances, including not only small plasma Di Cristina Hospital, Palermo); G. Rizzoni, S. Rinaldi (Nephrology di- solutes, but also the so-called middle molecules, with alysis and transplant unit, Ospedale Bambino Gesù, Roma); R. Coppo, B. Gianoglio (Nephrology dialysis and transplant unit, Ospedale Regina a molecular weight (MW) ranging from 0.3 to 5 kd, and Margherita, Torino). low-molecular mass proteins (MW 40 kd) [1]. Wellknown examples are parathyroid hormone (MW 9.5 kd), Key words: automated peritoneal dialysis, dialysate removal, cystatin C, 2 -microglobulin, inulin, clearance, Kt/V, solute removal index, mass 2 -microglobulin ( 2 m; MW 11.8 kd) and leptin (MW transfer. 16 kd) [2, 3]. In adult studies there has been increasing recognition Received for publication May 16, 2001 and in revised form October 18, 2001 of the influence of adequate solute clearance on patient Accepted for publication October 22, 2001 outcome in peritoneal dialysis (PD). Both clinical (feeling 2002 by the International Society of Nephrology of well-being and the absence of uremic symptoms) 1153

2 1154 Montini et al: Middle molecule removal in dialysis children Fig. 1. Experimental protocol. and biochemical (urea and creatinine clearance, and weekly Kt/V for urea) parameters are used to assess the adequacy of PD, even if there are limited data from intermittent PD therapies [4]. The assessment of dialysis adequacy in children is even more complicated, since patient size varies widely [5]. Furthermore, dialysis efficiency has significant effects on statural growth and nutritional parameters: Schaefer, Klaus and Mehls have demonstrated that the peritoneal transporter state is a weak, but significant determinant of growth and body weight gain in children [6]. Recently Verrina et al have proposed the solute removal index (SRI) as an index of dialysis efficiency focused on urea mass balance with specific advantages in the comparison of different dialysis techniques [7]. Very few data are available on the clearance of solutes with higher MW, which can contribute to uremic symptoms (for example, decreased appetite) and to the longterm outcome of the patient maintained by PD. Residual renal function has a major role: even relatively small residual urea clearances may contribute substantially to overall clearance among PD patients. Inulin (5.5 kd) already has been utilized as a marker of the clearance of middle molecules in adult hemodialyzed patients. Cystatin C, a low-mw plasma protein (13 kd) consisting of 120 amino acid residues, has been recently proposed as a very sensitive endogenous marker of changes in glomerular filtration rate (GFR). This protein might reflect the dialytic efficiency of PD in removing low-mw proteins from plasma. We have performed this study to assess the transport and peritoneal removal of substances with a MW up to 15 kd, and to evaluate the contribution of residual renal function in pediatric patients maintained by automatic nightly peritoneal dialysis. METHODS Patients Seventeen children (5 males) from five pediatric nephrology centers, with a mean age of 12 4 years (range, 5 to 18) undergoing automated PD (APD) were studied. Median duration of dialysis at time of enrollment was 15 months (range, 3 to 122), pre-dialysis body weight was kg (range, 12.0 to 53.5) and body surface area (BSA) was m 2. At the time of the study, none had any condition, such as chronic liver or lung dis- ease, malignancy or inflammatory disorders, likely to interfere with protein metabolism. All patients had been free from peritonitis for at least one month prior to the study. Ten patients had ml of urine output (median 475, range, 100 to 1200), 7 were anuric (no patient was anephric). Informed consent was obtained from par- ents and/or patients, as appropriate. Study protocol All patients were dialyzed with an automated, nightly intermittent PD (NIPD) standardized protocol: 12 hours, 12 exchanges with dwell times of 45 minutes, fill volume 1100 ml/m 2 of body surface area, 1.36% glucose solution. One hour before starting NIPD (Fig. 1), inulin (Jacopo Monico, Venezia, Italy) was administered as a single in- jection ( mg/kg, range from 94 to 175) within two minutes. Serum samples were withdrawn after 15, 40 and 60 minutes from the injection of inulin, to evaluate its vol- ume of distribution, and then NIPD was started. Blood, peritoneal dialysate and urine samples were taken as follows. At 0 minutes and 12 hours, blood (2 ml) for urea, creatinine, inulin, cystatin C, 2 m was taken; blood (1 ml) for inulin was taken at 15, 40, and 60, minutes, and 4 and 8 hours. The total amounts of urine and peritoneal drainage were collected, weighed and sampled (10 ml) for urea, creatinine, inulin, cystatin C, and 2 m assays. At the second NIPD cycle, 10 ml of the drained dialysate also were taken for the same assays. Analytical methods Inulin was measured by a previously described, rapid high-performance liquid chromatography (HPLC) method, utilizing ion moderated partition chromatography and evaporative light-scattering detection [8]. The

3 Montini et al: Middle molecule removal in dialysis children 1155 equipment consists of a liquid chromatograph containing Table 1. Pre- and post-dialysis biochemical parameters of the 17 patients studied the two-pumps model 510 (Waters Assoc., Milford, MA, USA), a detector Model 450, an autosampler Model 465, Plasma values Pre-dialysis Post-dialysis t test P and a chromatography, data system Model 450-MT (Kon- Urea mmol/l tron Instruments, Milan, Italy). Cystatin C was determined Creatinine lmol/l Inulin mg/ml by automated PETIA method (Dako, Milano, Italy; basic 2-microglobulin mg/l a measuring range covers cystatin-c concentrations from Cystatin-C mg/l a 0.40 to about 14.1 mg/l) [9], 2 m by the immunonephelometric a Post-values are more than pre-values method (Dade, Milano, Italy), and creatinine and urea were measured by enzymatic assay (Ortho Clinical Diagnostics, Milano, Italy). Statistical analysis Calculations Data are expressed as mean standard deviation. Differences Inulin single-shot clearance was calculated from the were evaluated by the paired and unpaired Stu- plasma inulin disappearance rate as the injected dose/ dent t test, where appropriate. Pearson correlation co- total area-under-the-plasma-curve (AUC) [10], and from efficients were calculated to assess possible associations dialysate and urine inulin appearance rate of 12 hours between clearance and plasma values of the different soas: mass transfer lutes. Normality of the distributions was assessed by Sha /AUC The least-squares iterative computerized fitting according to Gauss-Newton-Raphtests with two-tailed alpha values lower than JMP piro-wilk test. The null hypothesis was rejected for all son [11] was carried out on inulin plasma values using the standard biexponential model Aexp(-at) Bexp(-bt) (SAS, Cary, NC, USA) and Pro Fit (Quan- where t is time and A, a, B, b are non-linear fitting cothe statistical analysis and for the iterative computer- tum Soft, Zurich, CH) software programs were used for efficients. The total and 12-hour AUCs were calculated using fitting parameters by the formulas: AUC A/a ized fitting. B/b and AUC 0 12 A/a[exp(-at 0 ) exp(-at 12 )] B/b [exp(-bt 0 ) exp(-bt 12 )] [12]. The apparent distribution RESULTS space of inulin was calculated by the injected dose/ Pre- and post-dialysis blood levels of urea, creatinine, bauc, and was taken as extracellular volume measure inulin, 2 m and cystatin C of the 17 patients are shown (ECV, liters) [13]. in Table 1. Urea, creatinine and inulin plasma levels Clearances (L/week) were calculated for all solutes by were significantly lower after dialysis treatment; the two direct determination from dialysis fluids, urine and mean higher MW compounds 2 m and cystatin C showed an pre- and post-dialysis serum solute concentrations, based opposite behavior, significantly increasing their plasma on a single day collection. Weekly Kt/V was calculated levels as a consequence of dialysis ultrafiltration (UF). only for urea by direct determination from dialysis fluids, UF was similar in the anuric and non-anuric children urine and mean pre- and post-dialysis serum urea concen- ( vs ml). trations. Total body water (liters) was assumed as urea Plasma values of the following substances were sigdistribution space [14]. nificantly higher in anuric versus non-anuric children: cre- Peritoneal mass transfer area coefficients (MTAC, atinine (pre-dialysis vs mol/l, ml/min) were calculated from data obtained at the sec- P 0.001), cystatin C (pre-dialysis vs. 6.2 ond cycle of the NIPD session, as previously suggested 0.5 mg/l, P 0.037) and 2 m (pre-dialysis for adult patients by Garred, Canaud and Farrell [15] and vs mg/l, P 0.008); anuria did not influence adapted to children by Geary, Harvey and Balfe [16]. urea plasma levels significantly (pre-dialysis vs. Normalizations for MTAC and clearances were calcu mmol/l, P NS). As a consequence of the lated by 1.73 m 2 of body surface area. intravenous bolus, pre-dialysis plasma levels of inulin Mass transfer (MT) was calculated for all solutes by were not different; instead, post-dialysis plasma levels direct determination from dialysis fluids and urine with- were significantly higher in anurics than in non-anurics out applying any normalization or correction. ( vs mg/ml, P 0.020). Weekly SRI was calculated for all solutes as the ratio Bi-exponential disappearance single-shot inulin curves between mass transfer and predialysis body content [7, are shown in Figure 2. The half-life of the inulin distribu- 17, 18]. Predialysis body content was calculated for each tion phase was minutes, the half-life of the elimisolute by multiplying distribution space for predialysis nation phase was hours, and the 95% plasma serum concentrations. The distribution space was assumed elimination was days. The extracellular volume, to be total body water for urea and creatinine and extracel- evaluated as inulin distribution space, was L and lular volume for inulin, 2 m and cystatin C [2, 17 20]. represented % of body weight. A statistically

4 1156 Montini et al: Middle molecule removal in dialysis children Fig. 2. Bi-exponential disappearance single shot inulin curves. Inulin (100 mg/kg body weight) was injected at baseline (t 0 minutes). Each line corresponds to a single plasma clearance of inulin. The fast disappearance phase corresponds to the distribution phase and the slow disappearance to the real inulin clearance from the body. Table 2. Peritoneal, renal, and total clearances of various solutes with different molecular weights (MW) Urea Creatinine Inulin 2 -Microglobulin Cystatin C MW Daltons All patients (N 17) Total clearance L/week/1.73 m Patients with maintained diuresis (N 10) Peritoneal clearance L/week/1.73 m Peritoneal clearance % of total 69.2% 45.9% 35.9% 20.4% 36.6% Renal clearance L/week/1.73 m Renal clearance % of total 30.6% 54.0% 64.0% 79.5% 62.8% Total clearance L/week/1.73 m Anuric patients (N 7) Peritoneal clearance L/week/1.73 m Fig. 3. Relationship of peritoneal mass transfer area coefficients (MTAC) to molecular weights. There is an inverse non-linear relationship be- tween the molecular weight and the peritoneal diffusive capacity. Molecular weight (MW) is expressed in daltons. significant difference was observed when comparing inulin bi-exponential disappearance clearance ( ) and total clearance ( L/week/1.73 m 2, P 0.026) obtained from urinary and peritoneal inulin appearance. Total and separated (dialytic and urinary) clearance values for urea, creatinine, inulin, cystatin C and 2 m are summarized in Table 2. Data of clearances are also expressed as the percentage (dialytic vs. renal) of the total values in the ten children who maintained residual renal function, showing progressive decrease of the dialytic percentage with increase in the MW. Similarly, peritoneal MTAC, normalized for 1.73 m 2 of body surface, showed a decreased slope that was inversely proportional to the MW of the substance, as a hyperbolic function (Fig. 3). Total clearances were significantly higher in non-anuric versus anuric children for creatinine (P 0.008) and for cystatin C (P 0.026); no differences were observed in urea, inulin and 2 m beta-2-microglobulin (Table 2).

5 Montini et al: Middle molecule removal in dialysis children 1157 Table 3. Peritoneal, renal, and total mass transfer (MT) of various solutes with different molecular weights (MW) Urea Creatinine Inulin 2 -Microglobulin Cystatin-C MW Daltons All patients (N 17) Total MT mg Patients with maintained diuresis (N 10) Peritoneal MT mg Renal MT mg Total MT mg Anuric patients (N 7) Peritoneal MT mg All values are expressed as absolute solute output in mg of a single automated peritoneal dialysis (APD) session without any normalization or correction. Table 4. Peritoneal, renal, and total solute removal index (SRI) of various solutes with different molecular weights (MW) Urea Creatinine Inulin 2 -Microglobulin Cystatin-C MW Daltons Distribution compartment TBW TBW ECV ECV ECV All patients (N 17) Total SRI ( 100) Patients with maintained diuresis (N 10) Peritoneal SRI Renal SRI Total SRI Anuric patients (N 7) Peritoneal SRI All values are expressed on a weekly basis and in percentage of pre-dialysis body content. The distribution compartments are assumed to be total body water (TBW) L ( % of body weight) and extracellular volume (ECV) L ( % of body weight) for different solutes. SRI is the solute removal index. Total, peritoneal and renal urea weekly Kt/V in the quacy is mandatory, especially for this percentage of 10 children who maintained residual renal function was young patients , and , respectively. Adult studies [22] have suggested that higher clearances Peritoneal urea weekly Kt/V in the 7 anuric patients was of small molecules are associated with better sur , total urea weekly Kt/V in the total group vival and lower morbidity and [23] have set the weekly of 17 children was MT and SRIs are shown targets at 2.0 for Kt/V and 60 L/1.73 m 2 for creatinine in Tables 3 and 4. clearance, with an increase of 10% for NIPD. Similar or Plasma cystatin C values showed a significant inverse greater targets have been extended to pediatric patients correlation with renal inulin clearance (r 0.615; P [24 26] ) and total creatinine clearance (r 0.558; P Recently markedly elevated leptin (a low-mw plasma 0.020). protein, product of fat cells, which regulates food intake, The ratio between the renal clearance of inulin and the through modulation of satiety signals, and energy expenother four solutes showed mild tubular reabsorption of diture in animal models) levels have been documented in urea ( ) and a much more consistent reabsorpdialysis; uremic patients, especially in those treated by peritoneal tion of 2 m ( ) and cystatin C ( ); tuchanges this may contribute to uremic anorexia and bular secretion of creatinine was observed ( ). in body composition [27]. This low-mw plasma protein could be one of the many substances, which DISCUSSION accumulate in a uremic organism. In fact, normal kidneys not only excrete water, electrolytes, and small molecular Data from the Italian Registry of Pediatric Chronic end-products of metabolism, but they also have a role Peritoneal Dialysis shows that 297 children were main- in removing larger molecules: peptides and low-mw protained by CPD during the years 1986 to 1997 [21]. CPD teins [1]. patients represented an increasing percentage of all chil- In the clinical setting blood concentrations of low-mw dren on chronic dialysis in the Italian Pediatric Dialysis substances are utilized to monitor dialysis efficiency, and Centers: from 42.6% in 1986, to 64.5% in Nine little attention is paid to compounds with higher MW percent of the children remained on CPD longer than [28]. This aspect could be particularly important in patients five years; therefore, an effort to optimize dialysis ade- with no residual diuresis, who depend completely

6 1158 Montini et al: Middle molecule removal in dialysis children on dialysis efficiency. Recent studies in adult hemodialy- an alternative efficiency dialytic index, to be utilized as a sis patients show that the use of high flux membranes unified basis for comparing different dialysis techniques removing more middle molecules ensures an excellent [7, 17, 18]. We have calculated SRIs values (Table 4) dialysis quality, influencing the clinical outcome of patients not only for urea, but also for creatinine, inulin, 2 m and in several areas ( 2 m associated amyloidosis, re- cystatin C. The distribution space was assumed to be covery from acute renal failure and mortality of chronic total body water for urea and creatinine, and extracellu- hemodialysis patients) [29]. Indeed, we have shown that lar volume for inulin, 2 m and cystatin C. SRI values for residual renal function has a central role in removing urea are similar to the values reported by Verrina et al some low-mw plasma proteins and larger middle mole- [7]. To the best of our knowledge, there are no SRI values cules. Urea is mainly removed from the plasma by peritoneal reported for molecules with a higher MW. It is intercules. dialysis (69.2%); inulin, 2 m and cystatin C by esting to note that the percentage of the removal index renal clearance (64.0%, 79.5% and 62.8%, respectively) is distributed in a similar proportion to the respective in the patients with urine output (Table 2). Therefore, clearances, between the kidney and the peritoneum for patients with no diuresis remove higher MW substances the different molecules. If clearances decrease following with greater difficulty. the increase in MW in a scale from 77.9 (creatinine) to Urea weekly Kt/V values, as well as peritoneal and renal 12.2 ( 2 m) L/week/1.73 m 2, SRI decreases from 2.37 to clearances, showed satisfactory values when com- 1.23, respectively. This means that normalizing removal pared to the recommended targets [22 26] in both anuric by the solute content of the body at the beginning of and non-anuric patients. As recently reported in a study the treatment, and therefore taking into consideration on APD pediatric patients [30], the recommended targets the distribution space, could allow a more useful compar- for creatinine clearance are more difficult to meet, ison of middle molecules and small protein removal than at least by peritoneal dialysis alone; in our experience, normalizing by body surface area. mean creatinine clearance was unsatisfactory in anuric In conclusion, the evaluation of PD efficiency may be children (47.8 L/week/1.73 m 2 vs. the recommended value determined more effectively by taking into account the of 60 in adults) and very satisfactory in children with a clearance not only of the standard small solutes, but preserved diuresis (83 L/week/1.73 m 2 ). The central role also of middle molecules and low-mw proteins, which of the residual diuresis has been previously shown in better reflect the complexity of uremia. Peritoneal clearadult patients [31]: it emerged as the most important de- ances and SRIs tend to decrease following the increase terminant of serum low-mw protein concentration; trans- in MW of the substance, and removal of the middle moleperitoneal clearance was dependent mainly on the size cules is superior when residual renal function is mainof the protein. The dwell time emerged as an important tained. Therefore, more attention should be paid to the factor only for high ( 60 kd) MW proteins. In our pe- removal of middle molecules. Further studies should be diatric patients the MTAC showed a similar result for undertaken to evaluate whether removing them has a small MW proteins. Therefore, it is clear that 1 ml/min of clinical impact and to determine threshold levels. inulin renal clearance is different from 1 ml/min of inulin peritoneal clearance, because there is progressively ACKNOWLEDGMENTS increasing peritoneal resistance to the transport of sub- This paper was presented in part at the European Society of Pedistances with increasing MW, especially when it is greater atric Nephrology (2000) and at the American Society of Nephrology than 5 kd (Table 2). Furthermore, even in end-stage renal (1999). failure, the kidney has an active tubular role in creati- Reprint requests to Giovanni Montini, M.D., Nephrology, Dialysis nine secretion, and 2 m and cystatin C reabsorption. The and Transplant Unit, Pediatric Department, University Hospital, Via peritoneal clearance of cystatin C appears to be greater Giustiniani, 3, Padova, Italy. than that of 2 m, despite the fact that cystatin C has the montini@pediatria.unipd.it largest MW and the smallest MTAC. This could be partly due to the high variability of 2 m, and an influence of the REFERENCES shape and molecular radius of the proteins. 1. Bergström J, Whele B: Clinical implication of middle and larger molecules, in The Kidney (5 th ed, vol 26), edited by Brenner BM, Our data also show that plasma values of creatinine, Philadelphia, Saunders, 1996, pp cystatin C and 2 m were significantly higher in anuric than 2. Vanholder R, De Smet R: Pathophysiologic effects of uremic in non-anuric children. Renal diuresis is inversely corre- retention solutes. J Am Soc Nephrol 10: , 1999 lated with serum cystatin C levels; therefore, patients withtion of serum leptin levels in children with chronic renal failure. 3. Daschner M, Tonshoff B, Blum WF, et al: Inappropriate eleva- out residual renal function have higher plasma levels of European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 9: , 1998 cystatin C than patients with residual diuresis, even when the usual biochemical parameters of dialysis efficiency 4. Burkart JM, Henrich WL: Adequacy of continuous peritoneal dialysis, in Uptodate in Nephrology and Hypertension, July 1999 are satisfactory. It has been previously suggested that SRI represents 5. Balfe JW: Peritoneal dialysis, in Pediatric Nephrology (2nd), ed-

7 Montini et al: Middle molecule removal in dialysis children 1159 ited by Holliday MA, Barratt TM, Vernier RC, Baltimore, Wil- nutritional status in haemodialysis patients. Nephrol Dial Transplant liam & Wilkins, 1987, pp : , Schaefer F, Klaus G, Mehls O: Peritoneal transport properties 20. Guyton AC: Textbook of Medical Physiology (8th ed). Philadelphia, and dialysis dose affect growth and nutritional status in children WB Saunders, 1991, pp on chronic peritoneal dialysis. Mid-European Pediatric Peritoneal 21. Verrina E, Perfumo F, Calevo MG, et al: The Italian Pediatric Dialysis Study Group. J Am Soc Nephrol 10: , 1999 Chronic Peritoneal Dialysis Registry. Perit Dial Int 19(Suppl 2): 7. Verrina E, Brendolan A, Gusmano R, Ronco C: Chronic renal S479 S483, 1999 replacement therapy in children: Which index is best for adequacy? 22. Canada USA (CANUSA) Peritoneal Dialysis Study Group: Kidney Int 54: , 1998 Adequacy of dialysis and nutrition in continuous peritoneal dialysis: 8. Marsilio R, Naturale M, Manghi P, et al: Rapid and simple Association with clinical outcomes. J Am Soc Nephrol 7:198 determination of inulin in biological fluids by high-performance 207, 1996 liquid chromatography with light-scattering detection. J Chromatogr 23. Golper TA, Twardowski ZJ, Warady BA, et al: Dose and ade- B Biomed Sci Appl 744: , 2000 quacy. Perit Dial Int 17(Suppl 3):S40 S41, Kyhse Andersen J, Schmidt C, Nordin G, et al: Serum cystatin 24. NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis C, determined by a rapid, Automated Particle-Enhanced Turbi- Adequacy. National Kidney Foundation. Am J Kidney Dis 30 dimetric method, is a better marker than serum creatinine for (Suppl 2):S67 S136, 1997 glomerular filtration rate. Clin Chem 40: , Holtta T, Ronnholm K, Jalanko H, Holmberg C: Clinical outcome 10. Florijn KW, Barendregt JN, Lentjes EG, et al: Glomerular filtration of pediatric patients on peritoneal dialysis under adequacy rate measurement by single-shot injection of inulin. Kid- control. Pediatr Nephrol 14: , 2000 ney Int 46: , Schaefer F, Wolf S, Klaus G, et al: Higher KT/V urea associ- 11. Draper NR, Smith H: Applied Regression Analysis (2 nd ed). New ated with greater protein catabolic rate and dietary protein intake York, Wiley, pp , in children treated with CCPD compared to CAPD. Mid-Euro- 12. Bianchi C: Measurement of the glomerular filtration rate, in Prog- pean Pediatric CPD Study Group (MPCS). Adv Perit Dial 10:310 ress in Nuclear Medicine (vol 2), Basel, Karger, 1971, pp , Gibaldi M, Perrier D: Pharmacokinetics (2 nd ed). New York, Dek- 27. Stenvinkel P, Lindholm B, Lonnqvist F, et al: Increases in serum ker, 1982, pp leptin levels during peritoneal dialysis are associated with inflam- 14. Mellits ED, Cheek DB: The assessment of body water and fat- mation and a decrease in lean body mass. J Am Soc Nephrol 11: ness from infancy to adulthood. Monogr Soc Res Child Dev 35: , , Laux C, Weiss B, Bonzel KE: Middle molecules in peritoneal 15. Garred LJ, Canaud B, Farrell PC: A simple kinetic model for equilibration test as a marker of peritoneal stress in children on assessing peritoneal mass transfer in chronic ambulatory peritoneal continuous peritoneal dialysis. Adv Perit Dial 15: , 1999 dialysis. ASAIO J 6: , Cheung AK, Leypoldt JK: The hemodialysis membranes: A his- 16. Geary DF, Harvey EA, Balfe JW: Mass transfer area coefficients torical perspective, current state and future prospect. Semin Nephrol in children. Perit Dial Int 14:30 33, : , Keshaviah PR: The solute removal index A unified basis for 30. Van der Voort JH, Harvey EA, Braj B, Geary DF: Can the comparing disparate therapies. Perit Dial Int 15: , 1995 DOQI guidelines be met by peritoneal dialysis alone in pediatric 18. Keshaviah PR, Star RA: A new approach to dialysis quantifica- patients? Pediatr Nephrol 14: , 2000 tion: An adequacy index based on solute removal. Semin Dial 7: 31. Kabanda A, Goffin E, Bernard A, et al: Factors influencing 85 90, 1994 serum levels and peritoneal clearances of low molecular weight 19. Canaud B, Garred LJ, Argiles A, et al: Creatinine kinetic modelling: A simple and reliable tool for the assessment of protein proteins in continuos ambulatory peritoneal dialysis. Kidney Int 48: , 1995

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School

More information

Chapter 2 Peritoneal Equilibration Testing and Application

Chapter 2 Peritoneal Equilibration Testing and Application Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate

More information

3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane

3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane 3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Evaluation and management of nutrition in children

Evaluation and management of nutrition in children Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence

More information

Advances in Peritoneal Dialysis, Vol. 23, 2007

Advances in Peritoneal Dialysis, Vol. 23, 2007 Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose

More information

Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis

Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis Kidney International, Vol. 57 (2000), 2603 2607 Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis PETER H. JUERGENSEN, A. LOLA MURPHY, KATHY A. PHERSON,

More information

Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis

Early Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 22, 2006 Hidetomo Nakamoto, 1,2 Hirokazu Imai, 2 Hideki Kawanishi, 2 Masahiko Nakamoto, 2 Jun Minakuchi, 2 Shinichi Kumon, 2 Syuichi Watanabe, 2 Yoshhiko Shiohira,

More information

Peritoneal Dialysis International, Vol. 16, pp /96$300+00

Peritoneal Dialysis International, Vol. 16, pp /96$300+00 Peritoneal Dialysis International, Vol. 16, pp 302-306 0896-8608/96$300+00 Printed in Canada All rights reserved Copyright 1996 International Society for Peritoneal Dialysis CONTINUOUS PERITONEAL DIAL

More information

The peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings

The peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings Peritoneal Dialysis International, Vol. 27, pp. 441 445 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis THE SHORT PET IN PEDIATRICS

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR

More information

PART ONE. Peritoneal Kinetics and Anatomy

PART ONE. Peritoneal Kinetics and Anatomy PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.

More information

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate

More information

The Physiology of Peritoneal Dialysis As Related To Drug Removal

The Physiology of Peritoneal Dialysis As Related To Drug Removal The Physiology of Peritoneal Dialysis As Related To Drug Removal Thomas A. Golper, MD, FACP, FASN Vanderbilt University Medical Center Nashville, TN thomas.golper@vanderbilt.edu Clearance By Dialysis Clearance

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

ad e quate adjective \ˈa-di-kwət\

ad e quate adjective \ˈa-di-kwət\ PD Prescriptions and Adequacy Monitoring: The Basics Fundamentals of Dialysis in Children Seattle, Washington February 27th, 2016 Colin White Steve Alexander Brad Warady Alicia Neu Franz Schaefer Bruce

More information

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE TABLE OF CONTENTS Introduction.... 3 SECTION 1: FUNDAMENTALS OF THE PRESCRIPTION.... 4 Getting Started: Patient Pathway to First Prescription.... 5 Volume

More information

You can sleep while I dialyze

You can sleep while I dialyze You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep

More information

Hyperphosphatemia is a strong predictor of overall

Hyperphosphatemia is a strong predictor of overall Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics Sunil V. Badve,* Deborah L. Zimmerman,* Greg A. Knoll, * Kevin D. Burns,*

More information

Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study

Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study Advances in Peritoneal Dialysis, Vol. 33, 2017 Kunal Malhotra, Ramesh Khanna Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study

More information

HEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI

HEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI HEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI high-flux Hemodiafiltration (HDF) Combination of two dialysis techniques, hemodialysis and hemofiltration:

More information

Phosphate Clearance in Peritoneal Dialysis: Automated PD Compared with Continuous Ambulatory PD

Phosphate Clearance in Peritoneal Dialysis: Automated PD Compared with Continuous Ambulatory PD Advances in Peritoneal Dialysis, Vol. 28, 2012 Dixie-Ann Sawin, Rainer Himmele, Jose A. Diaz Buxo Phosphate Clearance in Peritoneal Dialysis: Automated PD Compared with Continuous Ambulatory PD Although

More information

Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis

Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis original article http://www.kidney-international.org 26 International Society of Nephrology Superior dialytic clearance of b 2 -microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal

More information

02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN

02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN Assessment of the Peritoneal Membrane: Practice Workshop Marina Villano, MSN, RN, CNN marina.villano@fmc-na.com Objectives Briefly review normal peritoneal physiology including the three pore model. Compare

More information

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE

PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.

More information

Peritoneal Dialysis International, Vol. 16, pp /96$ AUTOMATED PERITONEAL DIALYSIS

Peritoneal Dialysis International, Vol. 16, pp /96$ AUTOMATED PERITONEAL DIALYSIS Peritoneal Dialysis International, Vol. 16, pp 307-315 0896-8608/96$300+00 Printed in Canada All rights reserved Copyright 1996 International Society for Peritoneal Dialysis RAPID DECLINE OF RESIDUAL RENAL

More information

PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond

PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond John Burkart, M.D. Wake Forest University Baptist Medical Center CMO Health Systems Management 8/2014 John M. Burkart, MD Educational Grants

More information

PD In Acute Kidney Injury. February 7 th -9 th, 2013

PD In Acute Kidney Injury. February 7 th -9 th, 2013 PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of

More information

Brief communication (Original)

Brief communication (Original) Asian Biomedicine Vol. 8 No. 1 February 2014; 67-73 DOI: 10.5372/1905-7415.0801.263 Brief communication (Original) Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with

More information

Intermittent peritoneal dialysis (IPD) has occasionally

Intermittent peritoneal dialysis (IPD) has occasionally Peritoneal Dialysis International, Vol. 32, pp. 142 148 doi: 10.3747/pdi.2011.00027 0896-8608/12 $3.00 +.00 Copyright 2012 International Society for Peritoneal Dialysis INTERMITTENT PERITONEAL DIALYSIS:

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance

Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine

More information

PART FOUR. Metabolism and Nutrition

PART FOUR. Metabolism and Nutrition PART FOUR Metaolism and Nutrition Advances in Peritoneal Dialysis, Vol. 19, 2003 Antonios H. Tzamaloukas, 1 Glen H. Murata, 2 Dorothy J. Vanderjagt, 3 Karen S. Servilla, 1 Roert H. Glew 3 Normalization

More information

PD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014.

PD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014. PD prescribing for all Pr Max Dratwa Honorary consultant, Nephrology-Dialysis CHU Brugmann Université Libre de Bruxelles BSN 22 March 2014 QUESTION: Which approach? One size fits all or haute couture?

More information

Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription

Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription Nephrol Dial Transplant (2002) 17: 380 385 Special Feature Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription Michel Fischbach 1, Constantinos J.

More information

Selection of modalities, prescription, and technical issues in children on peritoneal dialysis

Selection of modalities, prescription, and technical issues in children on peritoneal dialysis Pediatr Nephrol (2009) 24:1453 1464 DOI 10.1007/s00467-008-0848-4 EDUCATIONAL REVIEW Selection of modalities, prescription, and technical issues in children on peritoneal dialysis Enrico Verrina & Valeria

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation IJMS Vol 34, No 2, June 2009 Original Article Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation Reza Hekmat, Hamid Eshraghi Abstract Background:

More information

Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription

Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Advances in Peritoneal Dialysis, Vol. 34, 2018 Susie Q. Lew Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Urea kinetics (weekly Kt/V) greater than 1.7 generally define

More information

Drug Use in Dialysis

Drug Use in Dialysis (Last Updated: 08/22/2018) Created by: Socco, Samantha Drug Use in Dialysis Drambarean, B. (2017). Drug Use in Dialysis. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago. DIALYSIS

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are

More information

The greatest benefit of peritoneal dialysis (PD) is the

The greatest benefit of peritoneal dialysis (PD) is the Peritoneal Dialysis International, Vol. 26, pp. 150 154 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis COMBINATION THERAPY

More information

Intravenous Iron Does Not Affect the Rate of Decline of Residual Renal Function in Patients on Peritoneal Dialysis

Intravenous Iron Does Not Affect the Rate of Decline of Residual Renal Function in Patients on Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 22, 2006 Hemal Shah, Ashutosh Shukla, Abirami Krishnan, Theodore Pliakogiannis, Mufazzal Ahmad, Joanne M. Bargman, Dimitrios G. Oreopoulos Intravenous Iron Does Not

More information

Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial

Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial http://www.kidney-international.org & 2006 International Society of Nephrology original article Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled

More information

Unrestricted pore area (A 0 / x) is a better indicator of peritoneal membrane function than PET

Unrestricted pore area (A 0 / x) is a better indicator of peritoneal membrane function than PET Kidney International, Vol. 58 (2000), pp. 1773 1779 Unrestricted pore area (A 0 / x) is a better indicator of peritoneal membrane function than PET EVA JOHNSSON, ANN-CATHRINE JOHANSSON, BRITT-INGER ANDREASSON,

More information

Automated peritoneal dialysis (APD) has, in recent

Automated peritoneal dialysis (APD) has, in recent VIIth International Course on Peritoneal Dialysis May 23 26, 2000, Vicenza, Italy Peritoneal Dialysis International, Vol. 20, Suppl. 2 0896-8608/00 $3.00 +.00 Copyright 2000 International Society for Peritoneal

More information

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page 1589-1594 Using Serum Beta Trace Protein to Estimate Residual Kidney Function in Hemodialysis Patients Hesham M. El-Sayed, Hussein

More information

LLL Session - Nutritional support in renal disease

LLL Session - Nutritional support in renal disease ESPEN Congress Leipzig 2013 LLL Session - Nutritional support in renal disease Peritoneal dialysis D. Teta (CH) Nutrition Support in Patients undergoing Peritoneal Dialysis (PD) Congress ESPEN, Leipzig

More information

Vincenzo La Milia 1, Giuseppe Pontoriero 1, Giovambattista Virga 2 and Francesco Locatelli 1

Vincenzo La Milia 1, Giuseppe Pontoriero 1, Giovambattista Virga 2 and Francesco Locatelli 1 Nephrol Dial Transplant (2015) 30: 1741 1746 doi: 10.1093/ndt/gfv275 Advance Access publication 16 July 2015 Ionic conductivity of peritoneal dialysate: a new, easy and fast method of assessing peritoneal

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES Date written: January 2004 Final submission: May 2004 Peritoneal transport and ultrafiltration GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Peritoneal dialysis adequacy: A model to assess feasibility with various modalities

Peritoneal dialysis adequacy: A model to assess feasibility with various modalities Kidney International, Vol. 55 (1999), pp. 2493 2501 Peritoneal dialysis adequacy: A model to assess feasibility with various modalities JOSE A. DIAZ-BUXO, FRANK A. GOTCH, TOM I. FOLDEN, SHELDEN ROSENBLUM,

More information

Original Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration

Original Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration Original Article 133 Clinical Experience of One-Year Icodextrin Treatment in Peritoneal Dialysis Patients Chun-Shuo Hsu *, Chien-Yu Su **, Chih-Hung Chang ***, Kao-Tai Hsu **, King-Kwan Lam **, Shang-Chih

More information

Bacterial peritonitis is a common complication of peritoneal

Bacterial peritonitis is a common complication of peritoneal Peritoneal Dialysis International, Vol. 27, pp. 79 85 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis VANCOMYCIN DISPOSITION

More information

Physiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT

Physiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT Physiology of Blood Purification: Dialysis & Apheresis Jordan M. Symons, MD University of Washington School of Medicine Seattle Children s Hospital Outline Physical principles of mass transfer Hemodialysis

More information

Dialysis Adequacy (HD) Guidelines

Dialysis Adequacy (HD) Guidelines Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,

More information

What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test

What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 1 2 3 What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 4 Background information about the PET 1983 Dr. Twardowski and colleagues began measuring

More information

IN THE NAME OF GOD Uremic toxins I. Small (< 500 D); water soluble Surrogate marker urea or sodium (ionic dialysance) Rapidly produced in intracellular fluid compartment Large variability in intra-patient

More information

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31 Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to

More information

Evaluation of renal Kt/V as a marker of renal function in predialysis patients

Evaluation of renal Kt/V as a marker of renal function in predialysis patients Kidney International, Vol. 60 (2001), pp. 1540 1546 Evaluation of renal Kt/V as a marker of renal function in predialysis patients MARTIN K. KUHLMANN, MARTINA HECKMANN, WERNER RIEGEL, and HANS KÖHLER Department

More information

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center

More information

Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study

Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study Kidney International, Vol. 64 (2003), pp. 649 656 DIALYSIS TRANSPLANTATION Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study WAI-KEI LO, YIU-WING HO, CHUN-SANG

More information

Lecture-2 Review of the previous lecture:

Lecture-2 Review of the previous lecture: Lecture-2 Review of the previous lecture: -Kidney s function is to clean the blood by the removing of the waste plus adding some valuable substances -kidney failure will lead to death for many reasons,

More information

Peritoneal Dialysis Prescriptions: A Primer for Nurses

Peritoneal Dialysis Prescriptions: A Primer for Nurses Peritoneal Dialysis Prescriptions: A Primer for Nurses A Primer ABCs of PD R x Betty Kelman RN-EC MEd CNeph (C) Toronto General Hospital University Health Network Toronto, Ontario, Canada A moment to remember

More information

Smart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong

Smart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Smart APD prescription Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Costing Comparison of Different Modes of RRT in Hong Kong in 2011 (Per Year) HK$300,000 HK$250,000 HK$200,000 HK$150,000

More information

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate (GFR): Amount of blood that is filtered per unit time through glomeruli. It is a measure of the function of kidneys. The

More information

PART FOUR. Metabolism and Nutrition

PART FOUR. Metabolism and Nutrition PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,

More information

A longitudinal, five year survey of urea kinetic parameters in

A longitudinal, five year survey of urea kinetic parameters in Kidney International, Vol. 42 (1992), pp. 426 432 A longitudinal, five year survey of urea kinetic parameters in CAPD patients NORBERT H. LAMEIRE, RAYMOND VANHOLDER, DENISE veyt, MARIE-CHRISTINE LAMBERT,

More information

HDx THERAPY. Enabled by. Making possible personal.

HDx THERAPY. Enabled by. Making possible personal. HDx THERAPY Enabled by Making possible personal. THE NEXT HORIZON IN DIALYSIS IS CLOSER THAN YOU THINK PHOSPHATE UREA HDx BY THERANOVA EXPANDS YOUR RENAL POSSIBILITIES The new HDx therapy (expanded HD)

More information

THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 2 Outline of Presentation Refinements in our understanding

More information

BONE AND MINERAL METABOLISM in the PD PATIENT

BONE AND MINERAL METABOLISM in the PD PATIENT BONE AND MINERAL METABOLISM in the PD PATIENT John Burkart, MD Professor of Medicine/Nephrology Wake Forest University Baptist Medical Center Chief Medical Officer Health Systems Management Maria V. DeVita,

More information

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK Hemodiafiltration: principles and advantages over conventional HD Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009

More information

NIH Public Access Author Manuscript Am J Nephrol. Author manuscript; available in PMC 2015 January 22.

NIH Public Access Author Manuscript Am J Nephrol. Author manuscript; available in PMC 2015 January 22. NIH Public Access Author Manuscript Published in final edited form as: Am J Nephrol. 2012 ; 36(2): 144 150. doi:10.1159/000339937. Gentamicin Pharmacokinetics and Pharmacodynamics during Short-daily Hemodialysis

More information

Advances in Peritoneal Dialysis, Vol. 29, 2013

Advances in Peritoneal Dialysis, Vol. 29, 2013 Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate

More information

Peritoneal transport testing

Peritoneal transport testing THOROUGH CRITICAL APPRAISAL www.sin-italy.org/jnonline www.jnephrol.com Peritoneal transport testing Vincenzo La Milia Nephrology and Dialysis Department, A. Manzoni Hospital, Lecco - Italy Ab s t r a

More information

Acid-base profile in patients on PD

Acid-base profile in patients on PD Kidney International, Vol. 6, Supplement 88 (23), pp. S26 S36 Acid-base profile in patients on PD SALIM MUJAIS Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois Acid-base profile in patients

More information

Peritoneal Dialysis International, Vol.18, pp /98 $ TRANSPORT KINETICS IN CHILDREN

Peritoneal Dialysis International, Vol.18, pp /98 $ TRANSPORT KINETICS IN CHILDREN Peritoneal Dialysis International, Vol.18, pp 590-597 0896-8608/98 $300 + 00 Printed in Canada All rights reserved Copyright 1998 International Society for Peritoneal Dialysis INFLUENCE OF AGE, TIME, AND

More information

Title. Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): Issue Date Doc URL. Rights.

Title. Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): Issue Date Doc URL. Rights. Title The Administration of Ciprofloxacin During Continuou Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): 243-245 Issue Date 2009-05 Doc URL http://hdl.handle.net/2115/43035

More information

The kidneys maintain the body s homeostasis by

The kidneys maintain the body s homeostasis by Rationale for Daily Dialysis Umberto Buoncristiani, Riccardo Fagugli, Giuseppe Quintaliani, Hrissanti Kulurianu Nephrology-Dialysis Unit, Ospedale Regionale, Perugia, Italy. The kidneys maintain the body

More information

From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014

From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 Deux grands principes concernant la DP La dialyse péritonéale doit

More information

Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran

Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Dialysis Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Monir Sadat Hakemi, 1 Mehdi Golbabaei, 2 Amirahmad Nassiri, 3 Mandana

More information

Hemodialysis is a life-sustaining procedure for the treatment of

Hemodialysis is a life-sustaining procedure for the treatment of The Dialysis Prescription and Urea Modeling Biff F. Palmer Hemodialysis is a life-sustaining procedure for the treatment of patients with end-stage renal disease. In acute renal failure the procedure provides

More information

1.2 Synonyms There are several synonyms e.g. diaminomethanal, but in a medical context, this substance is always referred to as urea.

1.2 Synonyms There are several synonyms e.g. diaminomethanal, but in a medical context, this substance is always referred to as urea. Urea (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Urea 1.2 Synonyms There are several synonyms e.g. diaminomethanal, but in a medical context, this substance is always referred

More information

Ch 19: The Kidneys. Functional unit of kidneys:?? Developed by John Gallagher, MS, DVM

Ch 19: The Kidneys. Functional unit of kidneys:?? Developed by John Gallagher, MS, DVM Ch 19: The Kidneys Homeostatic regulation of ECF volume and BP Osmolarity 290 mosm Ion balance Na+ and K+, etc. ph (acid-base balance Excretion of wastes & foreign substances Hormone production EPO Renin

More information

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation

More information

Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1

Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1 Determination of Peritoneal Transport Characteristics With 24-Hour Dialysate Collections: Dialysis Adequacy and Transport Test1 Michael V. Rocco,2 Jean R. Jordan, and John M. Burkart MV. Rocco, J.M. Burkart,

More information

Ch 17 Physiology of the Kidneys

Ch 17 Physiology of the Kidneys Ch 17 Physiology of the Kidneys Review Anatomy on your own SLOs List and describe the 4 major functions of the kidneys. List and explain the 4 processes of the urinary system. Diagram the filtration barriers

More information

Nephrology Dialysis Transplantation

Nephrology Dialysis Transplantation Nephrol Dial Transplant (1996) 11 [Suppl 8]: 10-15 Nephrology Dialysis Transplantation Urea, sodium, and water changes in profiling dialysis H. Mann and S. Stiller ntroduction Control of osmolarity, as

More information

How to preserve residual renal function in patients with chronic kidney disease and on dialysis?

How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant (2006) 21 [Suppl 2]: ii42 ii46 doi:10.1093/ndt/gfl137 Original Article How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Raymond T.

More information

The low ph of conventional peritoneal dialysis (PD) solutions,

The low ph of conventional peritoneal dialysis (PD) solutions, Peritoneal Dialysis International, Vol. 29, pp. 158 162 Printed in Canada. All rights reserved. 0896-8608/09 $3.00 +.00 Copyright 2009 International Society for Peritoneal Dialysis EFFECTS OF IONIZED SODIUM

More information

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax American Journal of Nephrology Original Article: Basic Sciences Am J Nephrol 2003;23:7 77 DOI: 0.59/000068040 Received: July 23, 2002 Accepted: October 2, 2002 Renal Replacement in End-Stage Renal Disease

More information

Making possible personal.

Making possible personal. Making possible personal. HDX THERAPY, ENABLED BY THE THERANOVA DIALYZER HDF PERFORMANCE AND BEYOND AS SIMPLE AS HD The THERANOVA dialyzer, featuring an innovative membrane, effectively targets large middle

More information

The definition of peritoneal dialysis (PD) adequacy has

The definition of peritoneal dialysis (PD) adequacy has Peritoneal Dialysis International, Vol. 29, pp. 465 471 Printed in Canada. All rights reserved. 0896-8608/09 $3.00 +.00 Copyright 2009 International Society for Peritoneal Dialysis DIALYTIC PHOSPHATE REMOVAL:

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Optimising small solute clearances in peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Optimising small solute clearances in peritoneal dialysis GUIDELINES Optimising small solute clearances in peritoneal dialysis Date written: August 2004 Final submission: December 2004 GUIDELINES a. Aim to maintain residual renal function (RRF). Consider the use of ace

More information

Filtration and Reabsorption Amount Filter/d

Filtration and Reabsorption Amount Filter/d Renal Physiology 2011 Lisa M. Harrison-Bernard, PhD Contact me at lharris@lsuhsc.edu Renal Physiology Lecture 3 Renal Clearance and Glomerular Filtration Filtration and Reabsorption Amount Filter/d Amount

More information

Hemodiafiltration: practical points. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Hemodiafiltration: practical points. Rukshana Shroff Great Ormond Street Hospital for Children London, UK Hemodiafiltration: practical points Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009 No benefit from increased

More information

ACUTE KIDNEY INJURY AND RENAL REPLACEMENT THERAPY IN CHILDREN. Bashir Admani KPA Precongress 24/4/2018

ACUTE KIDNEY INJURY AND RENAL REPLACEMENT THERAPY IN CHILDREN. Bashir Admani KPA Precongress 24/4/2018 ACUTE KIDNEY INJURY AND RENAL REPLACEMENT THERAPY IN CHILDREN Bashir Admani KPA Precongress 24/4/2018 Case presentation SP 11month old Presenting complaint: bloody diarrhea, lethargy On exam: dehydration,

More information

(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD

(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD Kidney Function Tests (KFTs) IACLD CME, Monday, February 20, 2012 Mohammad Reza Bakhtiari, DCLS, PhD Iranian Research Organization for Science & Technology (IROST) Tehran, Iran Composition and Properties

More information

Free water transport: Clinical implications. Sodium sieving during short very hypertonic dialysis exchanges

Free water transport: Clinical implications. Sodium sieving during short very hypertonic dialysis exchanges Free water transport: Clinical implications Raymond T Krediet, MD,PhD University of Amsterdam Sodium sieving during short very hypertonic dialysis exchanges Nolph KD et al. Ann Int Med 1969;70:931-947

More information

10 Peritoneal dialysis and prescription monitoring

10 Peritoneal dialysis and prescription monitoring 10 Peritoneal dialysis and prescription monitoring B. MORGENSTERN INTRODUCTION Peritoneal dialysis (PO) is the major form of dialysis in use for infants and small children1,2. Data also suggests that pediatric

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information